In re Rivastigmine Patent Litigation

MEMORANDUM AND ORDER

JAMES C. FRANCIS IV, United States Magistrate Judge.

Defendants Watson Pharmaceuticals Inc. and Watson Laboratories, Inc. (collectively, “Watson”) and Sun Pharmaceutical Ltd. (“Sun”) seek to amend their answers and counterclaims against plaintiffs Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd. and Proterra AG (collectively, “Novartis”) to add a claim for attorneys’ fees.1 Novartis opposes the motion. For the reasons set forth below, the defendants’ motion is granted.

Background

This multidistrict litigation…